Home News & Events Press releases Press releases Category AcquisitionsAwardsCorporate earningsESGInvestor conferencesLeadershipTechnologyWhitepaper Year 20252024202320222021202020192018201720162015 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media What’s happening in ICON ICON Plc AI and predictive analytics are transforming clinical data risk management. CRAs are essential to successful trial. Read more on how tech empowers, not replaces, the CRA. Read the ACT article: https://ow.ly/ESvn50XB6TW 21h View post View webpage ICON Plc Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered... 23h View post View webpage ICON Plc Latest issue out now. Keep up to date on the latest changes with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribers who have discovered the convenience of this free monthly publication by signing u... 23h 1 View post View webpage ICON Plc Early phase neurodegenerative trials require careful planning, a patient-first approach, and biomarker strategies that drive progress. Tune in to our recent ASCPT-hosted webinar, where we explored: - How to define target... 12 Dec View post View webpage ICON Plc Innovation is accelerating progress in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions bring together advanced formulation design, real-time dose flexibility, and world-class CMC expertise to si... 11 Dec 2 View post View webpage ICON Plc ICON is proud to be recognised among the top global companies in the world for female employees. As of 31 December 2024, women make up 70% of our workforce and hold 60% of director-level and above roles—a powerful refle... 11 Dec View post View webpage ICON Plc With PubsHub Journals & Congresses, you’ll receive real-time alerts for updates, extensions, and changes to deadlines on your personalized watch list. That means fewer surprises - and better decisions. See how easy it is... 11 Dec 3 View post View webpage ICON Plc Data is the foundation of every decision in clinical development, yet the journey from first patient interaction to final submission is rarely seen in full. Our latest blog takes you behind the scenes to explore how inf... 11 Dec 2 View post View webpage ICON Plc Central laboratories are under more pressure than ever. Increasingly complex protocols, frequent amendments, and growing data demands require speed, agility, and uncompromising scientific integrity. At ICON Laboratories,... 11 Dec View post View webpage ICON Plc While multi-pronged global health efforts are essential to combatting HIV, systemic impediments persist. In ICON’s article, learn how drug developers can play a role in reshaping the future of HIV control, and what they ... 11 Dec View post View webpage ICON Plc Traditional trial settings often fail to reveal the added value of emerging HIV therapies. Explore how developers can plan trials that demonstrate the true advantages and utility of an HIV intervention in the article fro... 11 Dec 2 View post View webpage ICON Plc What should you consider when choosing a training dataset for your AI-enabled SaMD? Our whitepaper has the answers. Learn about AI models and data best practices and plan for your FDA Pre-Sub. Download it today. https://... 11 Dec 1 View post View webpage
